Avenue Therapeutics, Inc. (ATXI)
NASDAQ: ATXI · IEX Real-Time Price · USD
3.450
+0.040 (1.17%)
At close: Jul 19, 2024, 4:00 PM
3.390
-0.060 (-1.74%)
Pre-market: Jul 20, 2024, 9:27 AM EDT
Avenue Therapeutics Market Cap
Avenue Therapeutics has a market cap or net worth of $3.25 million as of July 22, 2024. Its market cap has decreased by -63.93% in one year.
Market Cap
3.25M
Enterprise Value
52.40K
1-Year Change
-63.93%
Ranking
Category
Stock Price
$3.45
Market Cap Chart
Since June 27, 2017, Avenue Therapeutics's market cap has decreased from $82.70M to $3.25M, a decrease of -96.07%. That is a compound annual growth rate of -36.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 3.20M | 52.38% |
| Dec 29, 2023 | 2.10M | -61.82% |
| Dec 30, 2022 | 5.50M | -67.65% |
| Dec 31, 2021 | 17.00M | -82.95% |
| Dec 31, 2020 | 99.70M | -37.69% |
| Dec 31, 2019 | 160.00M | 177.78% |
| Dec 31, 2018 | 57.60M | 54.84% |
| Dec 29, 2017 | 37.20M | -55.02% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptevo Therapeutics | 3.39M |
| Qualigen Therapeutics | 3.33M |
| 60 Degrees Pharmaceuticals | 3.31M |
| Ensysce Biosciences | 3.30M |
| ZyVersa Therapeutics | 3.26M |
| Healthcare Triangle | 3.20M |
| Aditxt | 3.19M |
| Protagenic Therapeutics | 3.12M |